Next generation sequencing technologies has brought significant changes in the sequencing process by providing high throughput, speed, flexibility and reduced sequencing cost. NGS can generate hundreds of nucleotide sequence data in a single sequencing run when programmed.
New York, NY -- (SBWIRE) -- 05/13/2019 -- Next-generation sequencing (NGS) also known as high-throughput sequencing is a relatively new method of DNA sequencing that is characterized by being highly scalable, which allows for an entire genome to be sequenced at one go . It is used to characterize various modern sequencing technologies such as Solid sequencing, Illumina (Solexa) sequencing, and Ion torrent: Proton / PGM sequencing and Roche 454 sequencing
High-throughput sequencing is revolutionizing microbiology and medicine with the continuous development of sequencing technologies, the cost for sequencing a human genome is continuously reducing. On breaking this barrier it is predicted that human genome sequencing will become common, which would help facilitate a brand new era in personalized medicine where genetic analyses will become central to understanding susceptibility to infectious diseases. These recent technologies allow DNA and RNA to be sequenced efficiently with lesser cost and time involved.
#This Reports Includes Segmental analysis, Regional analysis, Research Methodology, Competitive Landscape, Learn how to build the strategy and business case to implement Order Here@ https://www.marketindustryreports.com/checkout/3
Application of NGS in Oncology
Improvement in the overall NGS technology in terms of pipeline analyses, sequencing chemistry, data interpretation, reliability and costs has led to application of the technique in several fields of medical sciences, including oncology. The utilization of NGS technologies provides accurate and deeper knowledge regarding molecular basis of individual tumors, thereby providing a better, efficient and long lasting treatment option. According to Cancer Research UK, the number of cancer cases reported worldwide in the year 2018, was approximately around 17 million. It is further projected that within the period 2018-2040, the total incidence rate of worldwide cancer will increment by 62%. The growing incidences of cancer are anticipated to present a lucrative growth opportunity for the global Next generation sequencing (NGS) market in the coming years.
Key Points From Table of Contents
1. Research Framework
2. Data Collection Technique
3. Data Sources
3.1. Secondary Sources
3.2. Primary Sources
4. Market Estimation Methodology
4.1. Bottoms Up Approach
4.2. Top Down Approach
5. Data Validation and Triangulation
5.1. Market Forecasting Model
5.2. Limitations of the Study
5.3. Assumptions of the Study
1. Market Share Analysis (2018)
2. Key Strategies Assessment
2.1. New Product Launches
2.2. Merger & Acquisitions
2.3. Agreements, Collaborations, & Partnerships
2. Other Strategies
Access Sample PDF @ https://www.marketindustryreports.com/pdf/3
Imperative Questions Answered in this Report
- What are the strengths and weaknesses of the key vendors?
- What are the challenges to market growth?
- What is driving this market?
- What are the key market trends?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What will the market size be in 2030 and what will the growth rate be?
Increasing Demand of NGS for Clinical Application
The advent of NGS has led to significant changes in the scientific approach utilized for both clinical and research applications. Both RNA & DNA sequencing have been proven to be extremely useful for studying evolutionary relationships, mutation, sequence variation and other vital information associated with genes. The clinical applications of which has been pivotal in diagnosing germline diseases and understanding the genetic basis of various hereditary or chronic diseases among others. The growing incidences of several clinical ailments has directly contributed to the extensive adoption of NGS and other sequencing techniques, to obtain better understanding of the diseases and formulate necessary therapies for the same.
Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Next generation sequencing (NGS) Market by Product & Services (Pre-Sequencing Products & Service, Sequencing Services, Data Analysis, Storage, and Management), Technology (Sequencing By Synthesis Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing), Application (Diagnostics, Drug Discovery), End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers) - Global Analysis & Forecast 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/3/next-generation-sequencing-NGS-market
About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Phone: + 91 967-353-5933
Follow Us- LinkedIn | Twitter | Google+ | Face book